Modern radiation therapy for nodal non-hodgkin lymphoma - Target definition and dose guidelines from the international lymphoma radiation oncology group

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 1, 2014, Pages 49-58

  Illidge, Tim ^a   Specht, Lena ^b   Yahalom, Joachim ^c   Aleman, Berthe ^d   Berthelsen, Anne Kiil ^b   Constine, Louis ^e   Dabaja, Bouthaina ^f   Dharmarajan, Kavita ^c   Ng, Andrea ^g   Ricardi, Umberto ^h   Wirth, Andrew ⁱ  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOTHERAPY;

CLINICAL TARGET VOLUMES; INTENSITY-MODULATED; LOCAL TUMOR CONTROL; NON-HODGKIN LYMPHOMA; NORMAL TISSUE DAMAGE; RADIATION ONCOLOGY; STEERING COMMITTEE; TREATMENT TECHNIQUES;

ONCOLOGY;

ADVANCED CANCER; BREATH HOLDING; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TARGET VOLUME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DOSE RESPONSE; DOSIMETRY; FOLLICULAR LYMPHOMA; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HODGKIN DISEASE; HUMAN; IMAGE GUIDED RADIOTHERAPY; INDOLENT NODAL LYMPHOMA; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LARGE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; ORGANS AT RISK; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION ONCOLOGIST; REVIEW; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; SYSTEMIC THERAPY; THREE DIMENSIONAL IMAGING; TISSUE INJURY; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; COMBINED MODALITY THERAPY; HUMANS; LYMPHATIC IRRADIATION; LYMPHOMA, NON-HODGKIN; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN;

EID: 84897387358     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.01.006     Document Type: Review

References (41)

1. R.S. Bush, M. Gospodarowicz, and J. Sturgeon et al. Radiation therapy of localized non-Hodgkin's lymphoma Cancer Treat Rep 61 1977 1129 1136 (Pubitemid 8214076)
2. Z. Shi, S. Das, and D. Okwan-Duodu et al. Patterns of failure in advanced stage diffuse large B cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy Int J Radiat Oncol Biol Phys 86 2013 569 577
3. C. Zwick, G. Held, and N. Ziepert et al. The role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. Results from two prospective trials of the DSHNHL Haematol Oncol 31 Suppl. 1 2013 137
4. J.A. Dorth, L.R. Prosnitz, and G. Broadwater et al. Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging Int J Radiat Oncol Biol Phys 84 2012 762 767
5. J.A. Dorth, J.P. Chino, and L.R. Prosnitz et al. The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium 67 scans Ann Oncol 22 2011 405 410
6. L. Lowry, P. Smith, and W. Qian et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial Radiother Oncol 100 2011 86 92
7. S.J. Horning, E. Weller, and K. Kim et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484 J Clin Oncol 22 2004 3032 3038 (Pubitemid 41103714)
8. J. Phan, A. Mazloom, and L.J. Medeiros et al. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy J Clin Oncol 28 2010 4170 4176
9. J. Yahalom, and P. Mauch The involved field is back: Issues in delineating the radiation field in Hodgkin's disease Ann Oncol 13 2002 79 83 (Pubitemid 34567406)
10. J.I. Yu, H. Nam, and Y.C. Ahn et al. Involved lesion radiation therapy after chemotherapy in limited stage head and neck diffuse large B cell lymphoma Int J Radiat Oncol Biol Phys 78 2010 507 512
11. M.H. Verhappen, P.M.P. Poortmans, and E. Raaijmakers et al. Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin's lymphoma Radiother Oncol 109 2013 133 139
12. P. DeLuca, D. Jones, and R. Gahbauer et al. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT) [report 83] J ICRU 10 2010 1 106
13. B.S. Hoppe, C.H. Moskowitz, and D.A. Filippa et al. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity J Clin Oncol 26 2008 1858 1864
14. S. Kahn, C. Flowers, and Z. Xu et al. Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma? Int J Radiat Oncol Biol Phys 81 2011 175 180
15. J.W. Wolthaus, J.J. Sonke, and M. van Herk et al. Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients Int J Radiat Oncol Biol Phys 70 2008 1229 1238 (Pubitemid 351296128)
16. M. van Herk Errors and margins in radiotherapy Semin Radiat Oncol 14 2004 52 64 (Pubitemid 38168954)
17. T.P. Miller, S. Dahlberg, and R. Cassady et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non-Hodgkin's lymphoma N Engl J Med 339 1998 21 26 (Pubitemid 28304493)
18. A.K. Berthelsen, S. Holm, and A. Loft et al. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients Eur J Nucl Med Mol Imaging 32 2005 1167 1175 (Pubitemid 41355943)
19. K.A. Goodman, S. Toner, and M. Hunt et al. Intensity-modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206 (Pubitemid 40591943)
20. L.M. Xu, Y.X. Li, and H. Fang et al. Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma Int J Radiat Oncol Biol Phys 85 2013 1289 1295
21. C. Nieder, S. Schill, and P. Kneschaurek et al. Influence of different treatment techniques on radiation dose to the LAD coronary artery Radiat Oncol 2 2007 20
22. A. Paumier, M. Ghalibafian, and J. Gilmore et al. Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 82 2012 1522 1527
23. E.C. Moser, E.M. Noordijk, and P. Carde et al. Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials Clin Lymphoma Myeloma 6 2005 122 130
24. E.C. Moser, E.M. Noordijk, and F.E. van Leeuwen et al. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma Blood 107 2006 2912 2919
25. N.P. Brodin, I.R. Vogelius, and M.V. Maraldo et al. Life years lost - comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale Cancer 118 2012 5432 5440
26. S.M. Bentzen, L.S. Constine, and J.O. Deasy et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S3 S9
27. Specht L, Yahalom J, Illidge T, et al. Modern radiotherapy for Hodgkin lymphoma - field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 2013 Jun 8 [Epub ahead of print]. http://dx.doi.org/10.1016/j.ijrobp.2013.05.005.
28. J.M. Vose, M.J. Zhang, and P.A. Rowlings et al. Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry J Clin Oncol 19 2001 406 413 (Pubitemid 32112852)
29. S.T. Kahn, C.R. Flowers, and M.J. Lechowicz et al. Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: Optimizing involved-field radiotherapy in transplant patients Cancer J 11 2005 425 431 (Pubitemid 41725735)
30. B.S. Hoppe, C.H. Moskowitz, and Z. Zhang et al. The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma Bone Marrow Transplant 43 2009 941 948
31. T. Biswas, S. Dhakal, and R. Chen et al. Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era Int J Radiat Oncol Biol Phys 77 2010 79 85
32. A. Aref, S. Narayan, and S. Tekyi-Mensah et al. Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma Radiat Oncol Investig 7 1999 186 191 (Pubitemid 29310102)
33. C. Martens, D.C. Hodgson, and W.A. Wells et al. Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 64 2006 1183 1187
34. Y.D. Tseng, Y. Chen, and P. Catalano et al. Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma Int J Radiat Oncol Biol Phys 87 2 Suppl. 2013 S60
35. B.A. Campbell, N. Voss, and R. Woods et al. Long-term outcomes for patients with limited stage follicular lymphoma: Involved regional radiotherapy versus involved node radiotherapy Cancer 116 2010 3797 3806
36. R.L. Haas, P. Poortmans, and D. de Jong et al. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients Eur J Cancer 41 2005 1724 1730 (Pubitemid 41132632)
37. T. Girinsky, D. Guillot-Vals, and S. Koscielny et al. A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: Analysis of predictive parameters of response to treatment Int J Radiat Oncol Biol Phys 51 2001 148 155 (Pubitemid 32758874)
38. A.L. Russo, Y.H. Chen, and N.E. Martin et al. Low-dose involved-field radiation in the treatment of non-Hodgkin lymphoma: Predictors of response and treatment failure Int J Radiat Oncol Biol Phys 86 2013 121 127
39. C. Rossier, U. Schick, and R. Miralbell et al. Low-dose radiotherapy in indolent lymphoma Int J Radiat Oncol Biol Phys 81 2011 1 6
40. E.K. Chan, S. Fung, and M. Gospodarowicz et al. Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma Int J Radiat Oncol Biol Phys 81 2011 e781 e786
41. P. Hoskin, A. Kirkwood, and B. Bopova et al. FoRT: A phase 3 multi-center prospective randomized trial of low dose radiation therapy for follicular and marginal zone lymphoma Int J Radiat Oncol Biol Phys 85 2013 22